Explain this page
Arphra AIPlain-English read on Soligenix, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.23% | -4.04% | +5.96% | -65.04% | -73.94% | -67.91% | -76.11% | -96.36% | -99.85% | -99.98% | -100.00% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$0.43
400 sh
Bid
$0.41
100 sh
Ask
$0.48
25 sh
Spread
$0.072
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccineprnewswire.com·Jun 08, 2026
- Soligenix Applying for Vaccine Development Funding for Bundibugyo Ebola Vaccineprnewswire.com·Jun 08, 2026
- Soligenix Announces Recent Updates and First Quarter 2026 Financial Resultsprnewswire.com·May 08, 2026
Peers
No peer list available for SNGX.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|